Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

693644

registered interest
date	23/02/2017
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Welfare Tax Credits
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, what his timetable is for the review of cases of families who had their tax credits restricted or removed by Concentricx
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	65421
answer	answer is ministerial correction date of answer 03/03/2017 answer text <p>HM Revenue and Customs (HMRC) is carrying out a risk-based assurance review of the remaining High Risk Renewal 2016 cases where Concentrix has amended or terminated a claimant’s award but no Mandatory Reconsideration has been requested. HMRC is reviewing these cases to establish that decisions by Concentrix were properly made and communicated to claimants. Current plans indicate that this activity is expected to be completed by 31 March 2017.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 03/03/2017 10:06:44 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

692445

registered interest
date	21/02/2017
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Self-assessment
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, how much has been accrued to the public purse from fines levied by HM Revenue and Customs for late submission of tax returns in the last 12 months.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	64838
answer	answer is ministerial correction date of answer 01/03/2017 answer text <p>It is not possible to separately identify the figure for late submission of tax returns, but in 2015-16 the total accrued revenue for all fines and penalties was £1.0 billion. This is reported on page 160 of HM Revenue and Customs’ Annual Report and Accounts, which are available to view at: <a href="https://www.gov.uk/government/publications/hmrc-annual-report-and-accounts-2015-to-2016" target="_blank">https://www.gov.uk/government/publications/hmrc-annual-report-and-accounts-2015-to-2016</a>.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 01/03/2017 15:51:09 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

631072

registered interest
date	07/11/2016
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Soft Drinks: Taxation
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, how his Department plans to spend the revenue raised by the soft drinks industry levy.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	52093
answer	answer is ministerial correction date of answer 18/11/2016 answer text <p>The Treasury is working closely with the Department for Education to deliver the objectives of the levy including investing the revenue on doubling the primary PE and sport premium to £320 million a year.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 18/11/2016 14:42:00 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

631073

registered interest
date	07/11/2016
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Soft Drinks: Taxation
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, what assessment the Government has made of the potential effect on children's health of the soft drinks industry levy.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	52094
answer	answer is ministerial correction date of answer 16/11/2016 answer text <p>The Soft Drinks Industry Levy forms part of the Government’s Childhood Obesity Plan. The actions in this plan will significantly reduce England’s rate of childhood obesity within the next ten years.</p><p> </p><p>Since the Government announced the levy, some companies have already started to reformulate their products by removing added sugar content.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 16/11/2016 11:25:40 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

626511

registered interest
date	01/11/2016
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Inheritance Tax
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, what guidance his Department makes available to help prepare for the consequences of inheritance tax and other death-related costs.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	51295
answer	answer is ministerial correction date of answer 08/11/2016 answer text <p>Guidance is available at <a href="https://www.gov.uk/inheritance-tax" target="_blank">https://www.gov.uk/inheritance-tax</a>. More detailed technical guidance is available at https://www.gov.uk/hmrc-internal-manuals/inheritance-tax-manual.</p><p> </p><p>Bereaved customers and executors can also call the Inheritance Tax and Probate helpline and the Bereavement helpline for advice. In addition, information on inheritance tax is provided on the various inheritance tax forms and guides sent to executors following a death.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/11/2016 16:31:39 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

532959

registered interest
date	05/07/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to tackle antimicrobial resistance.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	41844
answer	answer is ministerial correction date of answer 13/07/2016 answer text <p>The Government has been at the forefront of action to address antimicrobial resistance (AMR).</p><p> </p><p>Our comprehensive UK Five Year AMR Strategy published in 2013, is an ambitious programme to slow the development and spread of AMR. The Strategy aims to prevent infection, protect the antibiotics that we have and promote the development of new drugs and alternative treatments. We are already seeing results: for example, between April and December 2015, two million fewer prescriptions were dispensed by general practitioners in England compared to the same period in 2014, a reduction of around 7%.</p><p> </p><p>Internationally, the United Kingdom supported successful negotiations of the AMR resolution at World Health Organization in 2015, mandating all countries to produce their own national action plans to tackle AMR. In the same year similar resolutions were passed relating to food and agriculture and animal health at the Food and Agriculture Organization and the World Organisation for Animal Health.</p><p> </p><p>Lord O’Neill’s independent review on AMR, commissioned by the Prime Minister in July 2014, published its final report in May. The Government will take forward its recommendations, as set out in its manifesto.</p><p> </p><p>The Government is also aiming to raise the profile of AMR yet higher on the global stage through our work to support a successful high level meeting on AMR at the United Nations General Assembly in September this year.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 13/07/2016 09:21:43 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

532962

registered interest
date	05/07/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tobacco: Packaging
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent assessment he has made of the effect of the introduction of plain packaging on rates of (a) smoking and (b) lung cancer.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	41847
answer	answer is ministerial correction date of answer 13/07/2016 answer text <p>The Department published a final Impact Assessment on 10 February 2015 which estimates that standardised packaging will result in around 390,000 additional adult quitters and 5,500 fewer child smokers.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 13/07/2016 09:37:21 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

532497

registered interest
date	04/07/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the timetable is for personalised medicines for inoperable cancers to be available on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	41831
answer	answer is ministerial correction date of answer 12/07/2016 answer text <p>Our understanding of how solid tumour cancers grow and mutate is being informed by the United Kingdom’s world-leading programme to sequence 100,000 human genomes. The potential benefit of this technology is recognised worldwide. In the UK, we are developing this technology as an integrated part of a national healthcare system to ensure the translation from bench to bedside happens as rapidly as possible. As far as the Department is aware, this is not being replicated in any other country in the world.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/07/2016 12:58:14 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

532498

registered interest
date	04/07/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to help reduce avoidable deaths in people below 70 years of age.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	41832
answer	answer is ministerial correction date of answer 12/07/2016 answer text <p>Reducing avoidable deaths and helping people to live better for longer are key priorities for the health and care system. Programmes focusing specifically on these challenges include the following:</p><p> </p><p>- investing up to £300 million a year by 2020 to improve earlier cancer diagnosis;</p><p>- providing screening programmes to identify disease earlier;</p><p>- running campaigns, such as the Be Clear on Cancer campaigns, to raise awareness and encourage people with symptoms to seek diagnosis earlier;</p><p>- rolling out our risk identification and management programmes, such as the NHS Health Check and the NHS Diabetes Prevention Programmes;</p><p>- introducing a range of tobacco control legislation, including: the standardised packaging of tobacco products, in order to discourage young people from starting smoking; helping adult smokers to quit; and a commitment to a new tobacco control plan in 2016 to continue to drive down smoking rates; and</p><p>- tackling other lifestyle factors such as helping people to drink more moderately, eat healthily and take more exercise.</p><p> </p><p>Local authorities have lead responsibility for improving the health of their local populations and this responsibility is supported by over £16 billion of funding over the spending review period. This is in addition to what the National Health Service spends on prevention, including through national immunisation and screening programmes.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/07/2016 14:54:38 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

532501

registered interest
date	04/07/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neuroblastoma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether new treatments for high-risk neuroblastoma are planned for availability on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	41830
answer	answer is ministerial correction date of answer 12/07/2016 answer text <p>Immunotherapy to treat cancer is an emergent area of clinical practice and, at this stage, there are only a few treatments that have been approved by the National Institute for Health and Care Excellence (NICE) that are commissioned by NHS England. There are currently two new immunotherapies for neuroblastoma in particular which are currently being considered by NICE - dinutuximab and APN311. At present both are only available via clinical trials in the United Kingdom.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/07/2016 12:57:14 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon